Southwestern Internal Medicine Conference: Pneumonias in adults due to mycoplasma, chlamydiae, and viruses

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Pneumonias in adults due to mycoplasma, chlamydiae, and viruses are a common clinical problem. These microorganisms cntribute to the etiologies in 6-35% of all cases of pneumonia and are the sole pathogens in 1-17% of hospitalized cases. Important trends and developments in the field include (1) the emergence of a Chlamydia psittaci strain (TWAR) that is passaged from human to human, causes a mycoplasma-like illness, and that is relatively resistant to erythromycin, (2) the recognition of respiratory syncytial virus as a pathogen in nursing home outbreaks and in immunosuppressed adults, (3) the continuing high lethality of fully developed influenza pneumonia, (4) the efficacy of acyclovir and adenine arabinoside in limiting the complications of varicella-zoster virus infections, and (5) the increasing frequency of pneumonia caused by cytomegalovirus and the severity of this disorder in highly immunosuppressed patients. Developments in the rapid diagnosis and therapy of respiratory syncytial virus infections with an aerosolized antiviral drug in children may pave the way for comparable advances in difficult pneumonias in adult patients.

Original languageEnglish (US)
Pages (from-to)45-64
Number of pages20
JournalAmerican Journal of the Medical Sciences
Volume294
Issue number1
StatePublished - 1987

Fingerprint

Chlamydia
Mycoplasma
Internal Medicine
Pneumonia
Viruses
Vidarabine
Chlamydophila psittaci
Respiratory Syncytial Virus Infections
Human Herpesvirus 3
Respiratory Syncytial Viruses
Acyclovir
Virus Diseases
Erythromycin
Nursing Homes
Cytomegalovirus
Human Influenza
Antiviral Agents
Disease Outbreaks

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{5ab434bc5afc47b4825c7af63fc3a6d8,
title = "Southwestern Internal Medicine Conference: Pneumonias in adults due to mycoplasma, chlamydiae, and viruses",
abstract = "Pneumonias in adults due to mycoplasma, chlamydiae, and viruses are a common clinical problem. These microorganisms cntribute to the etiologies in 6-35{\%} of all cases of pneumonia and are the sole pathogens in 1-17{\%} of hospitalized cases. Important trends and developments in the field include (1) the emergence of a Chlamydia psittaci strain (TWAR) that is passaged from human to human, causes a mycoplasma-like illness, and that is relatively resistant to erythromycin, (2) the recognition of respiratory syncytial virus as a pathogen in nursing home outbreaks and in immunosuppressed adults, (3) the continuing high lethality of fully developed influenza pneumonia, (4) the efficacy of acyclovir and adenine arabinoside in limiting the complications of varicella-zoster virus infections, and (5) the increasing frequency of pneumonia caused by cytomegalovirus and the severity of this disorder in highly immunosuppressed patients. Developments in the rapid diagnosis and therapy of respiratory syncytial virus infections with an aerosolized antiviral drug in children may pave the way for comparable advances in difficult pneumonias in adult patients.",
author = "Luby, {J. P.}",
year = "1987",
language = "English (US)",
volume = "294",
pages = "45--64",
journal = "The American journal of the medical sciences",
issn = "0002-9629",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Southwestern Internal Medicine Conference

T2 - Pneumonias in adults due to mycoplasma, chlamydiae, and viruses

AU - Luby, J. P.

PY - 1987

Y1 - 1987

N2 - Pneumonias in adults due to mycoplasma, chlamydiae, and viruses are a common clinical problem. These microorganisms cntribute to the etiologies in 6-35% of all cases of pneumonia and are the sole pathogens in 1-17% of hospitalized cases. Important trends and developments in the field include (1) the emergence of a Chlamydia psittaci strain (TWAR) that is passaged from human to human, causes a mycoplasma-like illness, and that is relatively resistant to erythromycin, (2) the recognition of respiratory syncytial virus as a pathogen in nursing home outbreaks and in immunosuppressed adults, (3) the continuing high lethality of fully developed influenza pneumonia, (4) the efficacy of acyclovir and adenine arabinoside in limiting the complications of varicella-zoster virus infections, and (5) the increasing frequency of pneumonia caused by cytomegalovirus and the severity of this disorder in highly immunosuppressed patients. Developments in the rapid diagnosis and therapy of respiratory syncytial virus infections with an aerosolized antiviral drug in children may pave the way for comparable advances in difficult pneumonias in adult patients.

AB - Pneumonias in adults due to mycoplasma, chlamydiae, and viruses are a common clinical problem. These microorganisms cntribute to the etiologies in 6-35% of all cases of pneumonia and are the sole pathogens in 1-17% of hospitalized cases. Important trends and developments in the field include (1) the emergence of a Chlamydia psittaci strain (TWAR) that is passaged from human to human, causes a mycoplasma-like illness, and that is relatively resistant to erythromycin, (2) the recognition of respiratory syncytial virus as a pathogen in nursing home outbreaks and in immunosuppressed adults, (3) the continuing high lethality of fully developed influenza pneumonia, (4) the efficacy of acyclovir and adenine arabinoside in limiting the complications of varicella-zoster virus infections, and (5) the increasing frequency of pneumonia caused by cytomegalovirus and the severity of this disorder in highly immunosuppressed patients. Developments in the rapid diagnosis and therapy of respiratory syncytial virus infections with an aerosolized antiviral drug in children may pave the way for comparable advances in difficult pneumonias in adult patients.

UR - http://www.scopus.com/inward/record.url?scp=0023254724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023254724&partnerID=8YFLogxK

M3 - Article

C2 - 3037901

AN - SCOPUS:0023254724

VL - 294

SP - 45

EP - 64

JO - The American journal of the medical sciences

JF - The American journal of the medical sciences

SN - 0002-9629

IS - 1

ER -